Back
Easterly Government Properties Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
50
DEA
Easterly Government Properties
Last Price:
$21.70
Seasonality Move:
2.86%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$16.93
Seasonality Move:
0.23%
Sell
50
Easterly Government Properties (DEA)
is a Sell
Is Easterly Government Properties a Buy, Sell or Hold?
-
The current Easterly Government Properties [DEA] share price is $22.02. The Score for DEA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
DEA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.41. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DEA Stock Price Chart
What is Easterly Government Properties's stock price today?
-
The Easterly Government Properties share price today is $22.02The current trend is relatively stagnant and DEA is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.41Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
DEA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 55.71 | Buy |
Chaikin Money Flow: | 24411 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.28 - 21.54) | Buy |
Bollinger Bands (100): | (21.8 - 28.26) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 44.4 | Sell |
Chaikin Money Flow: | 1588413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.89 - 18.97) | Sell |
Bollinger Bands (100): | (18.81 - 29.13) | Sell |
DEA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.58 | Buy |
20-day SMA: | 21.04 | Buy |
50-day SMA: | 22.38 | Sell |
200-day SMA: | 28.71 | Sell |
8-day EMA: | 21.57 | Buy |
20-day EMA: | 21.36 | Buy |
50-day EMA: | 22.44 | Sell |
200-day EMA: | 26.96 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.49 | Sell |
20-day SMA: | 17.89 | Sell |
50-day SMA: | 19.51 | Sell |
200-day SMA: | 28.26 | Sell |
8-day EMA: | 17.33 | Buy |
20-day EMA: | 17.78 | Sell |
50-day EMA: | 19.75 | Sell |
200-day EMA: | 28.32 | Sell |
Easterly Government Properties Earnings Growth & DEA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Easterly Government Properties Technical Analysis
May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |